ストックスクリーナーアプリを入手
1.70
2.86%
-0.05
アフターアワーズ：
1.70
Immunoprecise Antibodies Ltd (IPA) 最新ニュース
Is ImmunoPrecise Antibodies Ltd. a good long term investmentFree Investment Case Studies - jammulinksnews.com
What analysts say about ImmunoPrecise Antibodies Ltd. stockRapid return acceleration - Autocar Professional
ImmunoPrecise Antibodies Ltd. Stock Analysis and ForecastRapid portfolio appreciation - jammulinksnews.com
ImmunoPrecise Antibodies (OTCMKTS:IPATF) Stock Price Down 0.6% – What’s Next? - Defense World
What drives ImmunoPrecise Antibodies Ltd. stock priceDynamic profit expansion - Autocar Professional
ImmunoPrecise Strengthens Advisory Board with AI Expert Jeff Fried - TipRanks
ImmunoPrecise Antibodies appoints data expert Jeff Fried to advisory board - Investing.com Australia
ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board - Yahoo Finance
Is ImmunoPrecise Antibodies Ltd. stock a good hedge against inflationFree Investment Portfolio Suggestions - beatles.ru
why immunoprecise antibodies ltd. stock attracts strong analyst attentionMarket Beating Strategy - Newser
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025 - 01net
ImmunoPrecise Antibodies to Announce Q4 and FY 2025 Results - TipRanks
Why ImmunoPrecise Antibodies Ltd. stock attracts strong analyst attentionElite Stock Shortlist - Newser
How ImmunoPrecise Antibodies Ltd. stock performs during market volatilityShort Squeeze Radar - Newser
Tech Momentum Surges as IPA, HIT, SNYR, PNPN.V, KAPA and Others Drive Investor Awareness – More Stocks Inside - FinancialContent
What makes ImmunoPrecise Antibodies Ltd. stock price move sharplyFree Risk Assessment Services - Newser
ImmunoPrecise Regains Nasdaq Compliance, Strengthening Market Position - The Globe and Mail
ImmunoPrecise regains Nasdaq compliance as share price stabilizes By Investing.com - Investing.com South Africa
ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement - 01net
ImmunoPrecise Antibodies Ltd Inc. (IPA) Price Performance: The Role of Share Buybacks and Stock Splits - investchronicle.com
ImmunoPrecise regains Nasdaq compliance as share price stabilizes - Investing.com
ImmunoPrecise Antibodies Appoints Jon Lieber to Board of Directors - citybiz
ImmunoPrecise Antibodies Strengthens Board with Industry Veteran Jon Lieber - TipRanks
ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors - New Castle News
ImmunoPrecise Antibodies’ LENSai Platform Achieves Breakthrough in Epitope Mapping Accuracy - Insider Monkey
ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data - 01net
ImmunoPrecise Antibodies Skyrockets: AI-Powered Drug Discovery Takes Center Stage - RagingBull
ImmunoPrecise Antibodies (OTCMKTS:IPATF) Shares Down 0.5% – Here’s Why - Defense World
ImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® Technology | IPA Stock News - GuruFocus
Even With A 72% Surge, Cautious Investors Are Not Rewarding ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Performance Completely - simplywall.st
Market Recap: ImmunoPrecise Antibodies Ltd (IPA)’s Positive Momentum, Closing at 0.95 - DWinneX
We're Keeping An Eye On ImmunoPrecise Antibodies' (NASDAQ:IPA) Cash Burn Rate - Yahoo Finance
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Sees Large Growth in Short Interest - Defense World
ImmunoPrecise stock rating reiterated at Buy by H.C. Wainwright - Investing.com India
ImmunoPrecise Antibodies (IPA) Showcases Groundbreaking AI-Desig - GuruFocus
AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass - GuruFocus
Esty, America's Car-Mart, ImmunoPrecise - TradingView
ImmunoPrecise’s AI-Designed Peptides Surpass Semaglutide in Receptor Activation - TipRanks
0.51%
大文字化:
|
ボリューム (24 時間):